Cancer Genetics

Article	Citations
Potential role of microRNAs in the treatment and diagnosis of cervical cancer	47
The combination of WGS and RNA-Seq is superior to conventional diagnostic tests in multiple myeloma: Ready for prime time?	31
Identification of gene modules and hub genes in colon adenocarcinoma associated with pathological stage based on WGCNA analysis	29
DNA damaging agents and DNA repair: From carcinogenesis to cancer therapy	27
Comparison of four next generation sequencing platforms for fusion detection: Oncomine by ThermoFisher, AmpliSeq by illumina, FusionPlex by ArcherDX, and QIAseq by QIAGEN	21
MicroRNAs in breast cancer: New maestros defining the melody	18
Differences in cancer prevalence among CHEK2 carriers identified via multi-gene panel testing	18
Promoter hypermethylation regulates vitamin D receptor (VDR) expression in colorectal cancer-A study from Kashmir valley	17
TRK inhibitor activity and resistance in TRK fusion-positive cancers in adults	16
A melanoma patient with macrophage-cancer cell hybrids in the primary tumor, a lymph node metastasis and a brain metastasis	14
Evidence-based review of genomic aberrations in B-lymphoblastic leukemia/lymphoma: Report from the cancer genomics consortium working group for lymphoblastic leukemia	14
Alcohol consumption and risk of breast and ovarian cancer: A Mendelian randomization study	13
Assessing Genomic Copy Number Alterations as Best Practice for Renal Cell Neoplasia: An Evidence-Based Review from the Cancer Genomics Consortium Workgroup	12
The spectrum of tumors harboring BAP1 gene alterations	11
High methylation levels of histone H3 lysine 9 associated with activation of hypoxia-inducible factor 1α (HIF-1α) predict patients’ worse prognosis in human hepatocellular carcinomas	11
Integrative analysis of DNA methylation and gene expression profiles to identify biomarkers of glioblastoma	10
Tumor-intrinsic FABP5 is a novel driver for colon cancer cell growth via the HIF-1 signaling pathway	10
Lynch syndrome: further defining the pediatric spectrum	9
The promise of TRK inhibitors in pediatric cancers with NTRK fusions	9
NTRK-Rearranged soft tissue neoplasms: A review of evolving diagnostic entities and algorithmic detection methods	9
Intrahepatic cholangiocarcinoma development in a patient with a novel BAP1 germline mutation and low exposure to asbestos	9
Genotype-phenotype correlations among TP53 carriers: Literature review and analysis of probands undergoing multi-gene panel testing and single-gene testing	8
Late recurrence of lung adenocarcinoma harboring EGFR exon 20 insertion (A763_Y764insFQEA) mutation successfully treated with osimertinib	8
Comprehensive network analysis of the molecular mechanisms associated with sorafenib resistance in hepatocellular carcinoma	8
Double mutation of APC and BRCA1 in an Italian family	8

Classification of fluorescent R-Band metaphase chromosomes using a convolutional neural network is precise and fast in generating karyograms of hematologic neoplastic cells	8
EML4-ALK fusion variant.3 and co-occurrent PIK3CA E542K mutation exhibiting primary resistance to three generations of ALK inhibitors	7
Genotype-cancer association in patients with Fanconi anemia due to pathogenic variants in FANCD1 (BRCA2) or FANCN (PALB2)	7
Comprehensive analysis of PLKs expression and prognosis in breast cancer	7
Integrated genomic analysis using chromosomal microarray, fluorescence in situ hybridization and mate pair analyses: Characterization of a cryptic t(9;22)(p24.1;q11.2)/BCR-JAK2 in myeloid/lymphoid neo	7
LINE-1 retrotransposon encoded ORF1p expression and promoter methylation in oral squamous cell carcinoma: a pilot study	7
The clinical aspect of NTRK-fusions in pediatric papillary thyroid cancer	7
NRF2 metagene signature is a novel prognostic biomarker in colorectal cancer	7
Genetic heterogeneity and predictive biomarker for pulmonary sarcomatoid carcinomas	7
Evolution of histomorphologic, cytogenetic, and genetic abnormalities in an untreated patient with MIRAGE syndrome	7
NTRK point mutations and their functional consequences	6
Exosomal DNMT1 mRNA transcript is elevated in acute lymphoblastic leukemia which might reprograms leukemia progression	6
Invasive ACTH-producing pituitary gland neoplasm secondary to MSH2 mutation	6
Clinicopathological and molecular characterization of Brazilian families at risk for Lynch syndrome	6
A DNA methylation panel for high performance detection of colorectal cancer	6
Pan-tumor screening for NTRK gene fusions using pan-TRK immunohistochemistry and RNA NGS fusion panel testing	6
Characterizing false-positive fluorescence in situ hybridization results by mate-pair sequencing in a patient with chronic myeloid leukemia and progression to myeloid blast crisis	6
Genomic characterization of a PPP1CB-ALK fusion with fusion gene amplification in a congenital glioblastoma	6
MUC16 mutation is associated with tumor grade, clinical features, and prognosis in glioma patients	6
Whole-exome sequencing in osteosarcoma with distinct prognosis reveals disparate genetic heterogeneity	5
The oncogenic roles of NTRK fusions and methods of molecular diagnosis	5
Germline mutation in the NBR1 gene involved in autophagy detected in a family with renal tumors	5
Kinetics of DNA damage repair response accompanying initial hepadnavirus-host genomic integration in woodchuck hepatitis virus infection of hepatocyte	5
Enrichment of atypical hyperdiploidy and IKZF1 deletions detected by SNP-microarray in high-risk Australian AIEOP-BFM B-cell acute lymphoblastic leukaemia cohort	5
Myeloid neoplasm with a novel cryptic PDGFRB rearrangement detected by next-generation sequencing	5
Standardized evidence-based approach for assessment of oncogenic and clinical significance of NTRK fusions	5
Mutations in BRCA-related breast and ovarian cancer in the South African Indian population: A descriptive study	5
Diagnostic testing approaches for the identification of patients with TRK fusion cancer prior to enrollment in clinical trials investigating larotrectinib	5
Expression and potential immune involvement of cuproptosis in kidney renal clear cell carcinoma	5
A multimodal genomics approach to diagnostic evaluation of pediatric hematologic malignancies	5
A 10-gene-methylation-based signature for prognosis prediction of colorectal cancer	5
Microarray-based analysis of the BRAF V600 mutations in circulating tumor DNA in melanoma patients	5
Over‐expression of USP15/MMP3 predict poor prognosis and promote growth, migration in non-small cell lung cancer cells	5
Evaluation of DNA methylation in promoter regions of hTERT, TWIST1, VIM and NID2 genes in Moroccan bladder cancer patients	5
Association between XRCC3 Thr241Met polymorphism and risk of gynecological malignancies: A meta-analysis	5
Consensus molecular subtyping of colorectal cancers is influenced by goblet cell content	5
A Novel KMT2A-ARHGEF12 Fusion Gene Identified in a High-Grade B-cell Lymphoma	4
Identification of diagnostic DNA methylation biomarkers specific for early-stage lung adenocarcinoma	4
BRCA1 and BRCA2 whole cDNA analysis in unsolved hereditary breast/ovarian cancer patients	4
Lynch syndrome and Muir-Torre phenotype associated with a recurrent variant in the 3’UTR of the MSH6 gene	4
Generation and characterization of the Eµ-Irf8 mouse model	4
Pan-cancer analysis reveals that CTC1-STN1-TEN1 (CST) complex may have a key position in oncology	4
Content of circulating tumor DNA depends on the tumor type and the dynamics of tumor size, but is not influenced significantly by physical exercise, time of the day or recent meal	4
Molecular follow-up of first-line treatment by osimertinib in lung cancer: Importance of using appropriate tools for detecting EGFR resistance mutation C797S	4
Current concepts in breast cancer genomics: An evidence based review by the CGC breast cancer working group	4
The prognostic significance of FOXC2 gene expression in cancer: A comprehensive analysis of RNA-seq data from the cancer genome atlas	4
Molecular profiling of osteosarcoma in children and adolescents from different age groups using a next-generation sequencing panel	4
Multi-omics inference of differential breast cancer-related transcriptional regulatory network gene hubs between young Black and White patients	4
Identification and prevalence of potentially therapeutic targetable variants of major cancer driver genes in ampullary cancer patients in India through deep sequencing	4
Genetic variants as biomarkers for progression and resistance in multiple myeloma	4

Cancer risk among RECQL4 heterozygotes	4
Ataxia telangiectasia mutated germline pathogenic variant in adrenocortical carcinoma	4
Evaluation of hereditary/familial breast cancer patients with multigene targeted next generation sequencing panel and MLPA analysis in Turkey	4
Identification of KMT2A-ARHGEF12 fusion in a child with a high-grade B-cell lymphoma	4
BCL11A gene over-expression in high risk neuroblastoma	4
Mesothelin CAR‐T cells secreting PD‐L1 blocking scFv for pancreatic cancer treatment	3
BCR-ABL1 positive AML or CML in blast crisis? A pediatric case report with inv(3) and t(9;22) in the initial clone	3
Enhancement of MDM2 inhibitory effects through blocking nuclear export mechanisms in ovarian cancer cells	3
Identification of a novel resistance ALK p.(Q1188_L1190del) deletion in a patient with ALK-rearranged non–small-cell lung cancer	3
Therapy-related acute myeloid leukemia with KMT2A-SNX9 gene fusion associated with a hyperdiploid karyotype after hemophagocytic lymphohistiocytosis	3
Somatic tumor testing implications for Lynch syndrome germline genetic testing	3
Dynamics of cell-free DNA in predicting response in adult diffuse glioma on chemoradiotherapy	3
Hereditary inflammatory fibroid polyps caused by germline pathogenic variants in PDGFRA: Refining PDGFRA-mutation syndrome	3
t(5;12)(q31;p13)/ETV6::ACSL6 and t(6;9)(p23;q34)/DEK::NUP214 concurrence in acute myeloid leukemia: an unusual association of two rare abnormalities	3
Copy number assessment in the genomic analysis of CNS neoplasia: An evidence-based review from the cancer genomics consortium (CGC) working group on primary CNS tumors	3
Rare monosomy 7 and deletion 7p at diagnosis of chronic myeloid leukemia in accelerated phase	3
A new four-way complex translocation variant involving the t(8;5;21;4)(q21;q13;q22;q31) and the relocalization of AML1/ETO fusion gene	3
Integrating transcriptome-wide association study and copy number variation study identifies candidate genes and pathways for diffuse non-Hodgkin's lymphoma	3
Neurotrophic tyrosine receptor kinase fusion in pediatric central nervous system tumors	3
Genomic and transcriptomic somatic alterations of hepatocellular carcinoma in non-cirrhotic livers	3
Discovery of BRCA1/BRCA2 founder variants by haplotype analysis	3
The role of P62 in the development of human thyroid cancer and its possible mechanism	3
Distinct mechanisms of PTEN inactivation in dogs and humans highlight convergent molecular events that drive cell division in the pathogenesis of osteosarcoma	3
First report of t(5;11) KMT2A-MAML1 fusion in de novo infant acute lymphoblastic leukemia	3
Functional analysis of ATM variants in a high risk cohort provides insight into missing heritability	2
Double heterozygous pathogenic variants in the BRCA1 and BRCA2 genes in a patient with bilateral metachronous breast cancer	2
Novel MET exon 14 skipping analogs characterized in non-small cell lung cancer patients: A case study	2
Novel and recurrent germline mutations in the VHL gene in 5 Arab patients with Von Hippel-Lindau disease	2
Association of the KRAS genotype and clinicopathologic findings of resected non‐small‐cell lung cancer: A pooled analysis of 179 patients	2
Novel genomic signature predictive of response to immune checkpoint blockade: A pan-cancer analysis from project Genomics Evidence Neo-plasia Information Exchange (GENIE)	2
Integrated genetic profiling of archival pediatric high-grade glial tumors and reassessment with 2021 WHO classification of paediatric CNS tumours	2
TCGA dataset screening for genes implicated in endometrial cancer using RNA-seq profiling	2
Rare and potentially fatal ‐ Cytogenetically cryptic TNIP1::PDGFRB and PCM1::FGFR1 fusion leading to myeloid/lymphoid neoplasms with eosinophilia in children	2
Newly designed breakapart FISH probe helps to identify cases with true MECOM rearrangement in myeloid malignancies	2
Molecular profiling of gynecologic cancers for treatment and management of disease – demonstrating clinical significance using the AMP/ASCO/CAP guidelines for interpretation and reporting of somatic v	2
Expression of a novel type of KMT2A/EPS15 fusion transcript in FLT3 mutation-positive B-lymphoblastic leukemia with t(1;11)(p32;q23)	2
Analysis of polymorphisms in EGF, EGFR and HER2 genes in pancreatic neuroendocrine tumors (PNETs)	2
Pan-cancer genetic analysis of disulfidptosis-related gene set	2
Interpretative differences of combined cytogenetic and molecular profiling highlights differences between MRC and ELN classifications of AML	2
Genetic progression of post-transplant Burkitt-like lymphoma case with 11q-Gain/Loss and MYC amplification	2
Jumping translocation involving chromosome 13q in a patient with Crohn's Disease and inv(16)(p13.1q22)/CBFB-MYH11 acute myeloid leukemia	2
Trisomy 3, a sole recurrent cytogenetic abnormality in pediatric polymorphic post-transplant lymphoproliferative disorder (PTLD)	2
Determination of the key ccRCC-related molecules from monolayer network to three-layer network	2
A rare case of atypical chronic myeloid leukemia associated with t(8;22)(p11.2;q11.2)/ BCR-FGFR1 rearrangement: A case report and literature review	2
Necessity of multiplex ligation probe amplification in genetic tests: Germline variant analysis of the APC gene in familial adenomatous polyposis patients	2
A literature review and database of how the primary KIT/PDGFRA variant of a gastrointestinal stromal tumour predicts for sensitivity to imatinib	2
A novel missense mutation in the folliculin gene associated with the renal tumor-only phenotype of Birt-Hogg-Dubé syndrome	2
Twin-to-twin transmission of transient abnormal myelopoiesis without constitutional trisomy 21: A case report	2
MYC amplification on double minute chromosomes in plasma cell leukemia with double IGH/CCND1 fusion genes	2
Homologous recombination deficiency prediction using low-pass whole genome sequencing in breast cancer	2
Enumeration, characterisation and clinicopathological significance of circulating tumour cells in patients with colorectal carcinoma	2
A Case report: Co-occurrence of IMAGe syndrome and Rhabdomyosarcoma	2
Mitochondrial DNA polymorphisms and biogenesis genes in primary and metastatic uveal melanoma cell lines	2
CytoGPS: A large-scale karyotype analysis of CML data	2
A novel case of intrachromosomal amplification and insertion of RUNX1 on derivative chromosome 2 in pediatric AML	2
Synchronous driver gene alterations (EGFR L858R, T790M, and ROS1) rearrangements in a patient with early-stage lung adenocarcinoma	2
A novel, germline, deactivating CBL variant p.L493F alters domain orientation and is associated with multiple childhood cancers	2
Novel high–risk acute myeloid leukemia subgroup with ERG amplification and Biallelic loss of TP53	2
Somatic mutation variant analysis in rural, resectable non‐small cell lung carcinoma patients	2
Long-read nanopore sequencing enables accurate confirmation of a recurrent PMS2 insertion–deletion variant located in a region of complex genomic architecture	2
Vulvar Melanoma in association with germline MITF p.E318K variant	2
Distinct somatic DICER1 hotspot mutations in three metachronous ovarian Sertoli-Leydig cell tumors in a patient with DICER1 syndrome	2
Breast and colorectal cancer risks among over 6,000 CHEK2 pathogenic variant carriers: A comparison of missense versus truncating variants	1
Philadelphia chromosome- positive myelodysplastic syndrome with single lineage dysplasia	1
64. FAIR sharing of cancer GWAS data via the NHGRI-EBI GWAS catalog	1
Complex karyotype with double Philadelphia chromosome and T315I mutation results in blastic phase and extensive extramedullary infiltration in a chronic myeloid leukemia patient	1
Somatic NF1 mutations in pituitary adenomas: Report of two cases	1
Familial Cerebral Cavernous Malformation Syndrome with Concomitant Fourth Ventricular Ependymoma: True Association or Mere Coincidence?	1
Epithelial-mesenchymal transition-related gene prognostic index and phenotyping clusters for hepatocellular carcinoma patients	1
Malignant peripheral nerve sheath tumor on a patient with a maternally inherited novel NF1 gene pathogenic germline variant: Case report	1
Extracellular genetic materials and their application in clinical practice	1
t(10;12)(q24;q15): A new cytogenetic marker in hematological malignancies	1
NTRK-fusions in pediatric thyroid tumors: Current state and future perspectives	1
Patient with multiple genetically distinct thyroid nodules including papillary thyroid carcinoma harboring novel YWHAG-BRAF fusion	1
Concomitance of a novel RMDN2-ALK fusion and an EML4-ALK fusion in a lung adenocarcinoma	1
Acute myeloid leukemia with t(X;6)9p11;q23);MYB-GATA1 and female sex: GATA1 insufficiency may be insufficient for pathogenesis	1
Study on the use of Nanostring nCounter to analyze RNA extracted from formalin-fixed-paraffin-embedded and fresh frozen bladder cancer tissues [Cancer Genetics 268-269 (2022) 137-143]	1
Case report of a man with multiple paragangliomas and pathogenic germline variants in both NF1 and SDHD	1
Identification of variant APL translocations PRKAR1A-RARα and ZBTB16-RARα (PLZF-RARα) through the MI-ONCOSEQ platform	1
Mast cell leukemia with novel BRAF variant and concomitant atypical KIT variant	1

Sensitivity to dabrafenib and trametinib treatments in patients with non-small-cell cancer harboring BRAF compound mutations: A pooled analysis of BRAF p.V600E-positive advanced non-small-cell lung ca	1
Somatic tumor mutations in moderate risk cancer genes: Targets for germline confirmatory testing	1
A pediatric BAL case with double Ph chromosomes and trisomy 5	1
A variant e13a3 BCR-ABL1 fusion transcript in refractory adult B-cell acute lymphoblastic leukemia achieving complete remission with CAR-Tcell therapy	1
A founder CHEK2 pathogenic variant in association with kidney cancer	1
Longitudinal change of genetic variations in cetuximab-treated metastatic colorectal cancer	1
Copy number alterations identify a smoking-associated expression signature predictive of poor outcome in head and neck squamous cell carcinoma	1
Implementation of cytogenomic microarray with plasma cell enrichment enables better abnormality detection and risk stratification in patients with plasma cell neoplasia than conventional cytogenetics	1
Ossifying low grade endometrial stromal sarcoma with PHF1-BRD8 fusion	1
Gene expression-based immune infiltration analyses of liver cancer and their associations with survival outcomes	1
How to structure an oncogenetics service for the public health system: Report of the implementation of the first service in Northeastern Brazil	1
A novel ATRX splice variant causing acquired HbH disease in myelodysplastic syndrome with excess blasts-1	1
28. Next-generation sequencing as a tool for precision medicine in clinical oncology	1
Differences in the mitochondrial microsatellite instability of Keratoacanthoma and cutaneous squamous cell carcinoma	1
Clinical description & molecular modeling of novel MAX pathogenic variant causing pheochromocytoma in family, supports paternal parent-of-origin effect	1
Selection for or against escape from nonsense mediated decay is a novel signature for the detection of cancer genes	1
8. Integrating genomic and transcriptomic data to identify splice altering mutations across 35 cancer types	1
Paroxysmal nocturnal hemoglobinuria and myelodysplastic syndrome: Disappearance of cytogenetic abnormalities	1
14. Prenatal diagnosis of Acrofacial Dysostosis type 1 (Nager syndrome) by chromosomal microarray at the exon level	1
7. Adoption of optical genome mapping in clinical cancer cytogenetic laboratory: A stepwise approach	1
Evaluation of anti-angiogenic agent F16 for targeting glioblastoma xenograft tumors	1
Concurrent Pathogenic Variants of BRCA1, MUTYH and CHEK2 in a Hereditary Cancer Family	1
Clinical impact of 5ʹMYC or 3ʹMYC gain/loss detected by FISH in patients with aggressive B-cell lymphomas	1
A prognostic gene signature for predicting survival outcome in diffuse large B-cell lymphoma	1
A novel heptasomy 21 associated with complete loss of heterozygosity and loss of function RUNX1 mutation in acute myeloid leukemia	1
Evolution of germline TP53 variant classification in children with cancer	1
FANCA, TP53, and del(5q)/RPS14 alterations in a patient with T-cell non-Hodgkin lymphoma and concomitant Fanconi anemia and Li-Fraumeni syndrome	1
53. Genomic characterization of brain metastases identifies drivers of metastatic lung adenocarcinoma	1
45. Deconstruction of pancreatic ductal adenocarcinoma identifies survival-associated tumor microenvironmental communities	1
A rare CALR variant mutation and efficient peginterferon alfa-2a response in a patient with essential thrombocythemia	1
79. Extraction of multiple analytes in liquid biopsy may improve the diagnosis of breast cancer	1
Prognostic impact of molecular profiles and molecular signatures in clear cell ovarian cancer	1
22. Characterization of atypical iAMP21 observed in B-Lymphoblastic Leukemia (B-ALL): A retrospective study from Mayo Clinic	1
Identification of BRIP1, NSMCE2, ANAPC7, RAD18 and TTL from chromosome segregation gene set associated with hepatocellular carcinoma	1
Atypical teratoid rhabdoid tumor in a child with neurofibromatosis type 2: A novel dual diagnosis	1
Rapid FISH results within one hour	1
PTEN alterations in sporadic and BRCA1-associated triple negative breast carcinomas	1
Molecular determinants of clinical outcomes for anaplastic lymphoma kinase–positive non-small cell lung cancer in Chinese patients: A retrospective study	1
Clinical utility of chromosomal microarray in establishing clonality and high risk features in patients with Richter transformation	1
The hsa-miR-516a-5p and hsa-miR-516b-5p microRNAs reduce the migration and invasion on T98G glioblastoma cell line	1
When cascade testing for familial variant seems inadequate to provide clinically actionable information for blood relatives	1
24. Clinical considerations for migration between genome assemblies: Lessons learned in moving to GRCh38	1
43. Structural changes characterized by whole genome mate-pair sequencing in a case with ETV6/ABL1 gene fusion and atypical Chronic Myeloid Leukemia	0
43. Adapting CIViC, a cancer variant interpretation knowledgebase, to support variants in disorders of somatic mosaicism	0
Clinical exome sequencing identified POLB c.C1002A as a possible genetic cause in a family with hereditary cancer-predisposing syndrome	0
Pathogenicity reclassification of two BRCA1/BRCA2 exonic duplications after identification of genomic breakpoints and tandem orientation	0
High frequency of BCL2 gene rearrangement-negative follicular lymphoma in northwestern Italy	0
RNA profile of immuno‐magnetically enriched lung cancer associated exosomes isolated from clinical samples	0
67. Long noncoding RNAs encoding peptides in cancer	0
48. Crowdsourcing expert curation of somatic variants by the ClinGen Somatic Hematologic Cancer Taskforce	0
88. Significant association of BRCA1, BRCA2 and TP53 gene polymorphisms with breast cancer risk in Khyber Pakhtunkhwa, Pakistan	0
51. PS4 utilization for PIK3CA variants implicated in disorders of somatic mosaicism	0
134. Novel fusions in aggressive infant sarcomas: Expanding the scope of 'CIC-rearranged' sarcoma without CIC rearrangement	0
35. Frequencies of Turner syndrome abnormalities as detected by high resolution chromosomal microarray in products of conception and postnatal blood samples	0
116. Integrating methylation profiling into adult brain tumor diagnostics - the Australian experience	0
68. Validation of CNA detection using an amplicon-based targeted NGS panel for hematological malignancies	0
34. Discovery of circular RNAs through integration of short- and long-read RNA sequencing	0
56. Therapy-Related B-Lymphoblastic Leukemia in adults is associated with frequent TP53 alterations and inferior survival	0
123. Chromosomal microarray assists interpretation of cytogenetic abnormalities in hematopoietic malignancies	0
29. Launching a CGC initiative to support trainees and early career members: Survey results and analysis	0
28. Identification of TP53 germline variants in pediatric patients undergoing tumor testing	0
17. Multi-consortia initiative to standardize the representation and curation of oncogenic fusions	0
26. Community engagement for crowd-sourcing clinically relevant somatic variants, the CIViC experience.	0
Unfolded protein response signature unveils novel insights into breast cancer prognosis and tumor microenvironment	0
Detecting the “undetectable” alterations: Use of NGS to uncover high-risk alterations	0
20. Diagnostic utility and lessons learned from deep sequencing vascular malformations	0
60. Panning for neoantigens to demonstrate feasibility of neoantigen vaccines in canine melanoma	0
Pigmented (melanotic) myoepithelial tumor of soft tissue with EWSR1-KLF17 fusion	0
121. Single cell TCR sequencing identifies an enriched V(D)J repertoire in canine melanoma	0
21. A case of acute myeloid leukemia with gain of two copies of neocentromeric chromosome 11	0
51. Discerning cell types and states in spatial transcriptomics data using topic modelling	0
48. Utility of whole genome optical mapping (WGOM) in cytogenetic analysis of solid tumors and hematologic malignancies (HM)	0
68. Integrative analysis of genomic and transcriptomic data using RegTools to identify splice-altering mutations within bulk	0
30. Characterization of atypical iAMP21 observed in B-Lymphoblastic Leukemia (B-ALL): a 2.5-year retrospective study from the Mayo Clinic	0
85. Cell-type-specific genotypic interpretation in the human breast	0
65. Accurate neoantigen prediction depends on mutation position relative to patient-specific MHC anchor locations	0
55. A familial clinical presentation of neurofibromatosis type 1 co-segregates with a unique chromosomal abnormality	0
4. ETV6-ABL1 variant rearrangement described in a childhood ALL patient	0
23. Incidental findings on XON array: Our experience over the last two years	0
32. Genetic diagnosis of bone marrow failure syndromes: Strategies, yields, and challenges	0
18. Two distinct cell lines in one hepatoblastoma tissue block	0
Comprehensive FISH testing using FFPE tissue microarray of primary lymph node tissue identifies secondary cytogenetic abnormalities in Mantle Cell Lymphoma	0
Rare and favorable prognosis of pediatric acute lymphoblastic leukemia with TLS-ERG fusion gene: Case report with long-term follow-up and review of literature	0
22. Masked hypodiploid B-Cell Lymphoblastic Leukemia (B-ALL) characterized by SNP microarray in a Li Fraumeni syndrome patient with post therapy karyotype changes	0
58. Improving the molecular diagnosis of SBDS-related disorders by identifying rare gene conversion events.	0
23. Concurrent detection of CNVs and mutations using a myeloid malignancy NGS panel: Is it ready for prime time?	0
28. Detection of small mutations, copy number alterations and structural variations from targeted cfDNA sequencing in cancer	0
2. Large structural variations in inflammatory breast cancer identifies possible pathognomonic alterations	0
1. Microdeletion 13q12.2 in B cell acute lymphoblastic leukemia: Little but important!	0
Editorial Board	0
86. Whole genome sequencing of mouse derived cell-free DNA to develop a NF1-MPNST-PDX liquid biopsy model	0
67. NUP98 rearrangements in hematologic malignancies: A 4-year review from the genomics laboratory	0
135. Tumor deconvolution using comprehensive single-cell RNA sequencing cell type signatures	0
44. Reevaluation of copy number variant (CNV) classifications in the clinical laboratory setting: challenges, insights, and experiences with a laboratory-initiated process	0
Editorial Board	0